• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Tuberculosis Patient Mortality Rose Over Decade in Northeastern Thailand Study

by
November 16, 2026
in Health
Reading Time: 3 mins read
0
Tuberculosis Patient Mortality Rose Over Decade in Northeastern Thailand Study

Tuberculosis Patient Mortality Rose Over Decade in Northeastern Thailand Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

All-cause case fatality during treatment among patients diagnosed with tuberculosis in Sakon Nakhon Province, northeastern Thailand, increased steadily across a ten-year evaluation window, according to findings from a retrospective cohort study. Researchers examining provincial public health records reported that all-cause mortality during anti-tuberculosis therapy rose continuously from 3.5 percent in 2014 to 9.1 percent by 2023, demonstrating a statistically significant linear trend over the decade. Over that identical ten-year observation period, the overall treatment success rate documented across the participating provincial health centers dropped from 92.1 percent down to 82.6 percent.

Tuberculosis remains one of the primary causes of death from a single infectious agent worldwide, continuing to pose substantial clinical challenges to national health programs. In 2023, global epidemiological surveillance recorded an estimated 10.8 million new incident cases of tuberculosis alongside approximately 1.25 million tuberculosis-related deaths internationally. Despite considerable national and regional improvements achieved in tuberculosis control programs, long-term survival patterns among patients receiving clinical management in rural community settings remain poorly characterized. This knowledge gap is especially pronounced in northeastern Thailand, where rural healthcare delivery networks encounter sustained operational and geographic constraints.

To examine clinical trajectories, survival outcomes, and prognostic determinants over time, the research team conducted a comprehensive ten-year retrospective cohort study spanning fiscal years 2014 through 2023. The investigators extracted standardized clinical records representing 9,289 registered patients who presented with either pulmonary or extrapulmonary tuberculosis across Sakon Nakhon Province. All relevant patient entries were systematically retrieved from the electronic National TB Information System, commonly designated as NTIP. To execute precise time-to-event survival calculations, researchers refined this primary dataset to an evaluable cohort of 8,895 individuals after excluding 95 patients who transferred out of provincial facilities and 299 patients whose initial diagnoses were subsequently altered.

Demographic and clinical evaluations of the baseline cohort of 9,289 registered patients revealed a mean age of 52.6 years with a standard deviation of 16.7 years across the cohort. Demographic distribution showed that 63.6 percent of the participants were male, establishing a male-to-female ratio of 1.74 to 1 among all registered cases. In addition, clinical documentation confirmed that 21.6 percent of the registered population presented with documented HIV co-infection. Furthermore, baseline drug-susceptibility testing identified multidrug-resistant or rifampicin-resistant tuberculosis, clinically designated as MDR or RR-TB, in 0.4 percent of the registered patients.

Across the documented study population, the overall treatment success rate achieved during the observation interval stood at 85.6 percent. This combined success metric comprised 46.8 percent of patients documented as cured alongside 38.8 percent who successfully completed their prescribed anti-tuberculosis therapy. However, all-cause case fatality during treatment reached 7.4 percent across the entire cohort. Early mortality presented a pronounced clinical risk, with 3.8 percent of all registered patients dying within the initial two months of initiating medication. Among the subset of patients who died during therapy, the median survival duration was approximately 6.0 months, with a documented mean survival time of 6.6 months and a standard deviation of 3.0 months.

To determine independent factors governing patient survival, the researchers applied Kaplan-Meier survival curves, the log-rank test, and multivariable Cox proportional hazards regression models, defining statistical significance as a p-value below 0.05. In the multivariable Cox regression framework, all-cause mortality during treatment remained independently associated with advanced age. Patients aged 65 years or older exhibited significantly heightened mortality relative to younger age groups, generating an adjusted hazard ratio of 2.67 with a 95 percent confidence interval spanning 2.18 to 3.28. Concurrent HIV co-infection represented another major independent determinant of death, conferring an adjusted hazard ratio of 1.55 with a 95 percent confidence interval ranging from 1.30 to 1.84.

The study authors highlighted critical methodological qualifications and public health considerations when evaluating these survival trends. All reported mortality and case-fatality statistics reflect all-cause deaths occurring throughout the prescribed course of tuberculosis treatment rather than mortality strictly attributed to tuberculosis infection, because the primary cause of death was not reliably documented in the administrative registry. The authors concluded that the steady ten-year rise in case fatality underlines the pressing need for integrated and targeted tuberculosis interventions. These clinical strategies must prioritize older individuals, patients living with HIV co-infection, and geographically disadvantaged populations managed within rural provincial settings.

Subject of Research: All-cause mortality and clinical determinants during tuberculosis treatment in northeastern Thailand

Article Title: Survival and determinants of all-cause mortality during treatment among patients with pulmonary and extrapulmonary tuberculosis in Sakon Nakhon Province, Northeastern Thailand: a ten-year retrospective cohort study

Article References: Kedthongma, W., Usaprom, S., Sirikhetkon, S., Phakdeekul, W., & Phoosuwan, N. (2026). Survival and determinants of all-cause mortality during treatment among patients with pulmonary and extrapulmonary tuberculosis in Sakon Nakhon Province, Northeastern Thailand: a ten-year retrospective cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14805-2

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14805-2

Keywords: tuberculosis, pulmonary tuberculosis, extrapulmonary tuberculosis, all-cause mortality, case fatality rate, Sakon Nakhon Province, northeastern Thailand, retrospective cohort study, HIV co-infection, treatment success rate, early mortality, multivariable Cox regression, Kaplan-Meier survival analysis, National TB Information System, rifampicin-resistant tuberculosis, multidrug-resistant tuberculosis, rural healthcare

News Source: Ophelia Keating. (November 16, 2026). Tuberculosis Patient Mortality Rose Over Decade in Northeastern Thailand Study. Scienmag.

Tags: all-cause mortalitycase fatality rateearly mortalityextrapulmonary tuberculosisHIV co-infectionKaplan-Meier survival analysismultidrug-resistant tuberculosismultivariable Cox regressionNational TB Information Systemnortheastern Thailandpulmonary tuberculosisretrospective cohort studyrifampicin-resistant tuberculosisrural healthcareSakon Nakhon Provincetreatment success rateTuberculosis
Share12Tweet7Share2ShareShareShare1

Related Posts

Systematic Review Finds Multi-Disease Artificial Intelligence Lacks Prospective Clinical Trial Evidence

Systematic Review Finds Multi-Disease Artificial Intelligence Lacks Prospective Clinical Trial Evidence

November 18, 2026
Naringenin Inhibits Mycoplasma synoviae Growth and Biofilm Formation in Laboratory Study

Naringenin Inhibits Mycoplasma synoviae Growth and Biofilm Formation in Laboratory Study

November 18, 2026

Digital sensors reveal hidden muscle impairment patterns in rare inherited myopathies

November 18, 2026

COPD Linked to Selected Mobility Difficulties in Older Cancer Survivors

November 18, 2026

POPULAR NEWS

  • Novel Benzimidazole Schiff Bases Outperform Acarbose in Lab Glucosidase Tests

    Novel Benzimidazole Schiff Bases Outperform Acarbose in Lab Glucosidase Tests

    29 shares
    Share 12 Tweet 7
  • Latent Class Analysis Identifies Five Distinct Lifestyle and Metabolic Subtypes of Insulin Resistance

    29 shares
    Share 12 Tweet 7
  • Screening Reveals Developmental Delays in Many Pediatric Liver Transplant Recipients

    29 shares
    Share 12 Tweet 7
  • Randomized Balance Training Alters Movement Coordination Without Boosting Young Adult Stability

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Systematic Review Finds Multi-Disease Artificial Intelligence Lacks Prospective Clinical Trial Evidence

Six-Band Drone Multispectral Imaging and Deep Learning Map Poisonous Grassland Weeds

Tin-Modified Titanium Dioxide Nanocomposite Enhances Light Trapping for Perovskite Solar Cells

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.